Welcome to our dedicated page for Horizon Space Acquisition II SEC filings (Ticker: HSPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Horizon Space Acquisition II Corp. SEC filings document its status as a Cayman Islands blank-check issuer and the securities used in its SPAC structure. The record includes Form 8-K material-event reports covering material definitive agreements, direct financial obligations, charter amendment and deadline-extension matters, shareholder votes, governance topics, and capital-structure disclosures for ordinary shares, units, and rights listed under HSPT, HSPTU, and HSPTR. Filings also include annual-report timing notices and disclosure categories such as operating results, financial condition, risk factors, and emerging growth company status.
Horizon Space Acquisition II Corp. (HSPT) filed an 8-K to supplement its proxy materials for the February 12, 2026 business combination meeting with SL BIO Ltd. The update mainly adds two independent director nominees for the post-merger public company, SL Science Holding Limited (PubCo): Joseph Levinson and Qian (Hebe) Xu.
The filing also refreshes the expected beneficial ownership table for PubCo. Assuming 566,591,350 ordinary shares outstanding in a no-redemption scenario (and 559,956,923 in a maximum-redemption scenario), SL Link Holding Ltd., associated with William Wang, is expected to hold 333,832,129 shares, representing about 58.9% to 59.6% of PubCo’s voting power. Qian Xu is expected to beneficially own 20,000 shares.
The schedule and logistics for the business combination meeting remain unchanged. The meeting is set for 9:00 a.m. Eastern Time on February 12, 2026, with a redemption deadline of 5:00 p.m. Eastern Time on February 10, 2026, and shareholders of record as of December 29, 2025 remain entitled to vote.
Horizon Space Acquisition II Corp. is clarifying how public shareholders can redeem their shares around two key shareholder meetings tied to its proposed business combination with SL BIO Ltd. and a potential deadline extension.
The company explains that investors who already elected redemption for the February 12, 2026 Business Combination Meeting and want their shares redeemed whether the merger closes or the extension is approved must also instruct the transfer agent to redeem in connection with the Extension Proposals by 5:00 p.m. Eastern Time on February 11, 2026. If the Extension Meeting on February 13, 2026 is not held or the Extension Proposals are not implemented, those shares will instead be redeemed if the business combination is consummated, unless the shareholder withdraws the request.
The filing confirms there is no change to the Business Combination Meeting’s time, location, record date, or proposals, and reminds shareholders of the February 10, 2026 redemption deadline for that meeting and that record-date holders can vote even if they later sell their shares.
Horizon Space Acquisition II Corp. filed an update explaining how public shareholders can redeem their shares around its proposed business combination with SL BIO Ltd. and a related deadline extension vote. The company clarifies that investors who already requested redemption for the business combination must also submit instructions for the extension vote if they want redemptions to apply in either outcome.
The filing confirms there is no change to the date, time, location, or record date for the February 12, 2026 business combination meeting, and repeats the February 10, 2026 and February 11, 2026 redemption deadlines. It also highlights that the extension meeting on February 13, 2026 may not occur and outlines how that would affect redemption elections.
Horizon Space Acquisition II Corp. is updating shareholders on how to redeem shares around its proposed merger with SL BIO Ltd. and a possible deadline extension. The company explains that public shareholders who already elected to redeem for the February 12, 2026 Business Combination Meeting must also instruct the transfer agent to redeem in connection with the February 13, 2026 Extension Meeting by 5:00 p.m. Eastern Time on February 11, 2026 if they want redemption to apply whether the merger closes or the extension is approved.
Horizon notes that if the Extension Meeting is not held and the extension is not implemented, shares submitted for redemption for both meetings will be redeemed upon consummation of the Business Combination unless the request is withdrawn, while shares redeemed only for the Extension Meeting would not be redeemed in that scenario. The company confirms there is no change to the time, location, record date, purpose, or proposals for the Business Combination Meeting and reminds shareholders that related proxy and registration materials are available through the SEC.
Horizon Space Acquisition II Corp. filed an 8-K describing a press release that clarifies how public shareholders can redeem their shares around its proposed business combination with SL BIO Ltd. and related extension proposals.
Shareholders who already submitted redemption requests for the February 12, 2026 Business Combination Meeting and want their public shares redeemed whether the business combination closes or the extension is approved must instruct the transfer agent to redeem those shares for the Extension Proposals by 5:00 p.m. Eastern Time on February 11, 2026.
If the Extension Meeting on February 13, 2026 is not held and the Extension Proposals are not implemented, any shares submitted for redemption for both meetings will be redeemed upon consummation of the business combination unless the holder withdraws the request. The filing confirms there is no change to the time, location, record date or proposals for the Business Combination Meeting.
Horizon Space Acquisition II Corp. is asking shareholders to approve amendments to its charter and trust agreement at a February 13, 2026 extraordinary meeting. These changes would let the SPAC extend its deadline to complete an initial business combination, including the proposed SL Bio merger, from February 18, 2026 up to February 18, 2027 through up to twelve one‑month extensions.
For each monthly extension, the sponsor or its designee would deposit the lesser of $50,000 or $0.033 per remaining public share into the trust account. Public shareholders may redeem some or all public shares in connection with the extension vote for cash equal to their pro rata portion of the trust, which was about $10.53 per share as of December 29, 2025, compared with a Nasdaq closing price of $10.55 that day. If the extension is not approved and no deal closes by the current deadline (or existing extensions), the company may redeem all public shares and liquidate, and the rights in the units would expire worthless.
Horizon Space Acquisition II Corp. is postponing its extraordinary general meeting for the proposed business combination with SL BIO Ltd. from February 3, 2026 to February 12, 2026 at 9:00 a.m. Eastern Time, to allow additional time to engage with shareholders.
The record date remains December 29, 2025, and the meeting location, purpose and proposals are unchanged. The deadline for public shareholders to submit redemption requests is extended to 5:00 p.m. Eastern Time on February 10, 2026.
Horizon Space Acquisition II Corp. is postponing its extraordinary general meeting to approve its proposed business combination with SL BIO Ltd. The meeting, originally set for February 3, 2026, is now scheduled for February 12, 2026, at 9:00 a.m. Eastern Time to allow more engagement with shareholders.
The record date remains December 29, 2025, so only shareholders of record on that date may vote. Proxies already submitted remain valid unless changed. The deadline for public shareholders to submit redemption requests is extended to 5:00 p.m. Eastern Time on February 10, 2026. The meeting location, agenda, and proposals are unchanged.
Horizon Space Acquisition II Corp. postponed its extraordinary general meeting of shareholders to February 12, 2026 at 9:00 a.m. Eastern Time to allow more time to engage with shareholders about its proposed business combination with SL BIO Ltd.
The record date of December 29, 2025, meeting location in New York and virtually via teleconference, and all proposals remain unchanged. The deadline for public shareholders to submit redemption requests is now 5:00 p.m. Eastern Time on February 10, 2026.
Horizon Space Acquisition II Corp. (HSPT) has postponed its extraordinary general meeting to approve the proposed business combination with SL BIO Ltd. The meeting, originally set for February 3, 2026, is rescheduled to February 12, 2026 at 9:00 a.m. Eastern Time to allow more time to engage with shareholders.
The record date remains December 29, 2025, so only shareholders of that date may vote. The deadline for public shareholders to submit redemption requests is extended to 5:00 p.m. Eastern Time on February 10, 2026. The meeting location and all proposals in the previously mailed definitive proxy statement are unchanged.